IRS Will Allow Costs of Breast Pumps as Deductible Medical Expenses

By Alistair M. Nevius, J.D.

From the IRS

In a reversal of long-standing policy, the IRS has announced that it will treat expenses for breast pumps and supplies that assist in lactation as deductible medical expenses (Announcement 2011-14). The IRS also said that amounts that taxpayers are reimbursed for these expenses under a flexible spending arrangement, Archer MSA, health reimbursement arrangement, or health savings account will not be income to the taxpayer.

However, to be deductible, the taxpayers’ total medical expenses must still meet the 7.5% of adjusted gross income threshold and other requirements of Sec. 213.

The announcement does not offer any analysis of the IRS’s reasoning or explain why it has changed its position. It simply states that breast pumps and supplies that assist in lactation “are for the purpose of affecting a structure or function of the body of the lactating woman” and therefore are deductible under Sec. 213(d). Previously, the IRS had characterized breast pumps as “merely beneficial to general health, but are not for the purpose of affecting any structure or function of the body” (letter from Gregory F. Jenner, Acting Assistant (Tax Policy) (6/8/04)).

As recently as May 2009, the IRS position was that “[i]t is not within the authority of the Internal Revenue Service to classify breastfeeding equipment as medical care in contravention of current law. A change to the Internal Revenue Code must be made by Congress” (IRS Information Letter 2010-0173 (5/23/09)).

In early March, the IRS posted an updated Publication 502, Medical and Dental Expenses, reflecting this change.

Tax Insider Articles

DEDUCTIONS

Business meal deductions after the TCJA

This article discusses the history of the deduction of business meal expenses and the new rules under the TCJA and the regulations and provides a framework for documenting and substantiating the deduction.

TAX RELIEF

Quirks spurred by COVID-19 tax relief

This article discusses some procedural and administrative quirks that have emerged with the new tax legislative, regulatory, and procedural guidance related to COVID-19.